Top Markets
#1 aelf aelf +15.99%
#2 Status Status +9.29%
#3 TDCCP TDCCP +8.55%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +7.56%
#5 HOME HOME +7.01%
#6 Mina Protocol Mina Protocol +5.87%
#7 Magma Finance Magma Finance +5.51%
#8 Janction Janction +4.89%
#9 Ribbita by Virtuals Ribbita by Virtuals +3.92%
#10 StonkBroker StonkBroker +3.90%
Coin of the day
aelf aelf
Settings
Language
ENGLISH
Currency
USD
Theme
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
Rank in Stocks #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Share Price
$48.45
Last synced: 2026-08-28
Market Cap
$1.39B
Change (1 day)
1.16%
Change (1 year)
-
Country
US
Trade LB Pharmaceuticals Inc Common Stock (LBRX)

Category

Healthcare
Earnings for LB Pharmaceuticals Inc Common Stock (LBRX)
Earnings in 2026 TTM: 0
According to LB Pharmaceuticals Inc Common Stock latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for LB Pharmaceuticals Inc Common Stock from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH